Home LiteratureArticle Details
PMID: 14960621 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.

Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H

Abstract

Corticotropin-releasing hormone (CRH) and GABA have been implicated in depression, and there is reason to believe that GABA may influence CRH functioning. The levels of CRH, and mRNA for CRH-binding protein, CRH1, and CRH2 receptors, as well as various GABA(A) receptor subunits (alpha1, alpha2, alpha3, alpha4, alpha5, delta, and gamma2), were determined in several frontal cortical brain regions of depressed suicide victims and nondepressed individuals who had not died by suicide. Relative to the comparison group, CRH levels were elevated in frontopolar and dorsomedial prefrontal cortex, but not in the ventrolateral prefrontal cortex of suicide victims. Conversely, using quantitative PCR analyses, it was observed that, in frontopolar cortex, mRNA for CRH1, but not CRH2, receptors were reduced in suicide brains, possibly secondary to the high levels of CRH activity. In addition, mRNA of the alpha1, alpha3, alpha4, and delta receptor subunits was reduced in the frontopolar region of suicide victims. Interestingly, a partial analysis of the GABA(A) receptor functional genome revealed high cross-correlations between subunit expression in cortical regions of nondepressed individuals, suggesting a high degree of coordinated gene regulation. However, in suicide brains, this regulation was perturbed, independent of overall subunit abundance. These findings raise the possibility that the CRH and GABA(A) receptor subunit changes, or the disturbed coordination between these GABA(A) receptor subunits, contribute to depression and/or suicidality or are secondary to the illness/distress associated with it.

MeSH Terms
Brain/metabolism,pathology Carrier Proteins/genetics Corticotropin-Releasing Hormone/genetics Female Frontal Lobe/metabolism,pathology Humans Male Middle Aged Protein Subunits/genetics RNA, Messenger/biosynthesis Receptors, Corticotropin-Releasing Hormone/genetics Receptors, GABA-A/genetics Suicide Whites
Chemicals
CRF receptor type 2 Carrier Proteins Protein Subunits RNA, Messenger Receptors, Corticotropin-Releasing Hormone Receptors, GABA-A corticotropin releasing factor-binding protein CRF receptor type 1 Corticotropin-Releasing Hormone
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Merali Zul
University of Ottawa Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada.
Du Lisheng
Hrdina Pavel
Palkovits Miklos
Faludi Gabor
Poulter Michael O
Anisman Hymie
References (64)
64 references, click to expand
  1. Neural systems for behavioral activation and reward.
    Curr Opin Neurobiol. 1999 Apr;9(2):223-7 PMID: 10322190
  2. Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications.
    Neuroscience. 1999;91(4):1343-54 PMID: 10391441
  3. Corticotropin-releasing hormone receptor subtypes and emotion.
    Biol Psychiatry. 1999 Dec 1;46(11):1480-508 PMID: 10599478
  4. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
    Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):325-30 PMID: 10618417
  5. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.
    J Neurosci. 2000 Feb 1;20(3):1240-8 PMID: 10648728
  6. GABA(A) receptor subunit expression within hypophysiotropic CRH neurons: a dual hybridization histochemical study.
    J Comp Neurol. 2000 Apr 10;419(3):344-51 PMID: 10723009
  7. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
    Nat Genet. 2000 Apr;24(4):410-4 PMID: 10742108
  8. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.
    Arch Gen Psychiatry. 2000 Aug;57(8):729-38 PMID: 10920459
  9. Neuroimaging studies of mood disorders.
    Biol Psychiatry. 2000 Oct 15;48(8):813-29 PMID: 11063977
  10. Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?
    Prog Brain Res. 2000;126:397-412 PMID: 11105659
  11. Chronic stress regulates levels of mRNA transcripts encoding beta subunits of the GABA(A) receptor in the rat stress axis.
    Brain Res. 2000 Dec 22;887(1):118-24 PMID: 11134596
  12. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study.
    J Clin Psychopharmacol. 2001 Feb;21(1):53-8 PMID: 11199948
  13. Behavioral planning in the prefrontal cortex.
    Curr Opin Neurobiol. 2001 Apr;11(2):164-70 PMID: 11301235
  14. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders.
    Curr Opin Neurobiol. 2001 Apr;11(2):240-9 PMID: 11301246
  15. Effects of sodium valproate on corticotropin-releasing factor systems in rat brain.
    Neuropsychopharmacology. 2001 Jun;24(6):624-31 PMID: 11331142
  16. Regulation of pituitary corticotropin releasing hormone receptors.
    Peptides. 2001 May;22(5):769-74 PMID: 11337090
  17. gamma-Aminobutyric acid(A) receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development.
    J Neurochem. 2001 Jun;77(5):1266-78 PMID: 11389177
  18. Activity-induced expression of common reference genes in individual cns neurons.
    Lab Invest. 2001 Jun;81(6):913-6 PMID: 11406652
  19. Persistent corticotropin-releasing factor(1) receptor desensitization and downregulation in the human neuroblastoma cell line IMR-32.
    Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):115-27 PMID: 11483248
  20. Hippocampal GABAergic interneurons: a physiological perspective.
    Neurochem Res. 2001 Sep;26(8-9):899-905 PMID: 11699941
  21. Suicide, serotonin, and the brain.
    Crisis. 2001;22(2):66-70 PMID: 11727896
  22. [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims.
    Am J Psychiatry. 2002 Jan;159(1):66-73 PMID: 11772692
  23. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression.
    Curr Opin Pharmacol. 2002 Feb;2(1):23-33 PMID: 11786305
  24. The CRF peptide family and their receptors: yet more partners discovered.
    Trends Pharmacol Sci. 2002 Feb;23(2):71-7 PMID: 11830263
  25. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims.
    Am J Psychiatry. 2002 Mar;159(3):419-29 PMID: 11870006
  26. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.
    Mol Psychiatry. 2002;7 Suppl 1:S71-80 PMID: 11986998
  27. Treatment of mood disorders.
    Nat Neurosci. 2002 Nov;5 Suppl:1068-70 PMID: 12403988
  28. New directions in the development of antidepressants: the interface of neurobiology and psychiatry.
    Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S13-6 PMID: 12404664
  29. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems.
    J Pharmacol Exp Ther. 2003 May;305(2):434-9 PMID: 12606697
  30. Corticotropin-releasing hormone modulators and depression.
    Curr Opin Investig Drugs. 2003 Jan;4(1):46-50 PMID: 12625028
  31. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men.
    Mol Psychiatry. 2003 Mar;8(3):324-32 PMID: 12660805
  32. Central GABAergic systems and depressive illness.
    Neurochem Res. 2003 Jun;28(6):965-76 PMID: 12718451
  33. Elevated concentrations of CRF in the locus coeruleus of depressed subjects.
    Neuropsychopharmacology. 2003 Jul;28(7):1328-35 PMID: 12784115
  34. GABAergic dysfunction in mood disorders.
    Mol Psychiatry. 2003 Aug;8(8):721-37, 715 PMID: 12888801
  35. Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices.
    J Neurosci. 2003 Aug 27;23(21):7931-9 PMID: 12944524
  36. Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brains.
    Neuropsychobiology. 1992;26(1-2):33-6 PMID: 1335560
  37. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin.
    Br J Psychiatry. 1991 Jan;158:59-63 PMID: 1673078
  38. Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims.
    Eur Arch Psychiatry Clin Neurosci. 1991;241(3):139-44 PMID: 1790159
  39. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    J Clin Endocrinol Metab. 1991 Feb;72(2):260-71 PMID: 1846869
  40. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.
    Biol Psychiatry. 1990 Oct 1;28(7):603-8 PMID: 2171685
  41. The gabaergic hypothesis of depression.
    Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(3-4):341-51 PMID: 2664889
  42. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims.
    Arch Gen Psychiatry. 1988 Jun;45(6):577-9 PMID: 2837159
  43. Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims.
    Brain Res. 1988 Sep 13;460(1):114-23 PMID: 2851368
  44. Brain GABAB binding sites in depressed suicide victims.
    Psychiatry Res. 1988 Nov;26(2):119-29 PMID: 2853398
  45. Amino acid levels in depression: a preliminary investigation.
    J Psychiatr Res. 1988;22(3):159-64 PMID: 3225786
  46. GABA concentrations in forebrain areas of suicide victims.
    Biol Psychiatry. 1988 Jan 15;23(2):109-14 PMID: 3334879
  47. CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
    Am J Psychiatry. 1987 May;144(5):641-5 PMID: 3495188
  48. Assay of corticotropin releasing factor.
    Methods Enzymol. 1983;103:565-77 PMID: 6321896
  49. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.
    Science. 1984 Dec 14;226(4680):1342-4 PMID: 6334362
  50. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression.
    Am J Psychiatry. 1995 Sep;152(9):1372-6 PMID: 7653697
  51. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients.
    Neuroendocrinology. 1994 Oct;60(4):436-44 PMID: 7824085
  52. Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings.
    Psychopharmacol Bull. 1994;30(3):489-94 PMID: 7878187
  53. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures.
    Endocrinology. 1996 Jan;137(1):65-71 PMID: 8536643
  54. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims.
    Brain Res. 1995 Aug 7;688(1-2):121-33 PMID: 8542298
  55. GABA and mood disorders: a brief review and hypothesis.
    J Affect Disord. 1995 Aug 18;34(4):275-81 PMID: 8550953
  56. GABA uptake sites in frontal cortex from suicide victims and in aging.
    Neuropsychobiology. 1997;35(1):11-5 PMID: 9018018
  57. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions.
    Mol Psychiatry. 1996 Sep;1(4):336-42 PMID: 9118360
  58. Corticotropin-releasing factor binding sites in cortex of depressed suicides.
    Psychopharmacology (Berl). 1997 Nov;134(2):174-8 PMID: 9399381
  59. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala.
    J Neurosci. 1998 Jun 15;18(12):4758-66 PMID: 9614249
  60. The role of corticotropin releasing factor in depressive illness: a critical review.
    Neurosci Biobehav Rev. 1998 Sep;22(5):635-51 PMID: 9662725
  61. GABA function in mood disorders: an update and critical review.
    Life Sci. 1998;63(15):1289-303 PMID: 9768867
  62. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Depress Anxiety. 1998;8(2):71-9 PMID: 9784981
  63. The role of corticotropin-releasing factor in depression and anxiety disorders.
    J Endocrinol. 1999 Jan;160(1):1-12 PMID: 9854171
  64. Co-localization of corticotropin-releasing hormone with glutamate decarboxylase and calcium-binding proteins in infant rat neocortical interneurons.
    Exp Brain Res. 1998 Dec;123(3):334-40 PMID: 9860272
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2004-02-11
Pages
1478-85
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6730322
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com